:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
tirzepatide weight loss injections vs. Semaglutide for Tirzepatide is a New Medication
Description
Semaglutide: product labeling advises discontinuation at least 2 months before a planned pregnancy, reflecting its long elimination time and extended exposure window (153, 157, 158)
Recent large-scale cardiovascular trials also demonstrated that semaglutide 2.4mg reduced the risk of major adverse cardiovascular events (including heart attack and stroke) in patients with obesity and established heart disease
Generally, Medicare Part D plans do not cover medications prescribed solely for weight loss
Please consult your healthcare provider to learn if medications for binge eating may work for you
